Victoria Blinder, MD

Assistant Attending Physician
Office Phone:
646-888-4808
Education:
University of Michigan Medical School

Current Research Interests

Dr. Blinder’s main research interest is in ethnic disparities in survivorship outcomes among women treated for breast cancer. Dr. Blinder has conducted qualitative research on barriers to return to work among ethnically diverse breast cancer survivors in New York City. She is currently collaborating with colleagues at UCLA on a prospective longitudinal study of low-income uninsured or under-insured breast cancer survivors in California. The results of the first three years of follow-up were published in Cancer in 2012. Dr. Blinder received an American Cancer Society mentored research scholar grant in 2010 to conduct a multi-center study of ethnic differences in the impact of breast cancer on employment status, financial situation, and quality of life. This study is ongoing and is currently open at MSKCC and five community hospitals throughout New York City. She also received a career development award from the American Society of Clinical Oncology for her pilot work in this area. Additional research interests include patient-physician communication about treatment planning and survivorship as well as ethnic disparities in breast cancer care and the financial impact of breast cancer on economically disadvantaged populations.

Publications by Victoria Blinder

Blinder V, Elul B, Winikoff B. Mifepristone-misoprostol medical abortion: Who will use it and why? American Journal of Obstetrics and Gynecology. 1998, 179(5):1376. [PubMed Abstract]

Blinder V, Roboz GJ. Hematopoietic growth factors in myelodysplastic syndromes. Current Hematology Reports. 2003, 2(6):453-458. [PubMed Abstract]

Blinder V, Chadburn A, Furman RR, Mathew S, Leonard JP. Improving outcomes for patients with Burkitt lymphoma and HIV. AIDS Patient Care and STDs, 2008, 22(3):173-185. [PubMed Abstract]

Blinder V, Fisher S. The role of environmental factors in the etiology of lymphoma. Cancer Investigation, 2008, 26(3):306-316. [PubMed Abstract]

Gold HT, Hall MJ, Blinder V, Schackman BR. Cost effectiveness of pharmacogenetic testing for UGT1A1 before irinotecan administration for metastatic colorectal cancer. Cancer 2009, 115(17):3858-3867. [PubMed Abstract]

Blinder VS, Patil S, Thind A, Diamant A, Hudis CA, Basch E, Maly RC. Return to work in low-income Latina and non-Latina white breast cancer survivors: A 3-year longitudinal study. Cancer 2011, Aug 25 [Epub ahead of print]. [PubMed Abstract]

Blinder VS, Murphy MM, Vahdat LT, Gold HT, de Melo-Martin I, Hayes MK, Scheff RJ, Chuang E, Moore A, Mazumdar M. Employment after a breast cancer diagnosis: A qualitative study of ethnically diverse urban women. Journal of Community Health 2011, Nov 23 [Epub ahead of print]. [PubMed Abstract]